Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Site × Anastrozole × Clear all

Sponsor

Conditions

Breast Neoplasms 67 Neoplasms 7 Breast Neoplasms, Male 4 Neoplasm Metastasis 3 Carcinoma, Intraductal, Noninfiltrating 3 Arthralgia 3 Triple Negative Breast Neoplasms 2 Sexual Dysfunction, Physiological 1 Seizures 1 Recurrence 1 Pain 1 Osteoporosis 1 Obesity 1 Multiple Endocrine Neoplasia Type 1 1 Lethal Congenital Contracture Syndrome 2 1 Joint Diseases 1 Invasive Breast Cancer 1 Hypogonadism 1 Granulosa Cell Ovarian Cancer 1 Fractures, Bone 1 Erectile Dysfunction 1 Epilepsy 1 Carcinoma, Non-Small-Cell Lung 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Advanced Metastatic Breast Cancer 1 Advanced Breast Carcinoma 1

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 4 pembrolizumab 3 napabucasin 3 Paclitaxel 3 Irinotecan 3 pralsetinib 2 patritumab 2 Standard of Care 2 Pemetrexed 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Ascorbic Acid 2 Albumin-Bound Paclitaxel 2 valrubicin 1 sotorasib 1 selpercatinib 1 ribociclib 1 relatlimab 1 pamiparib 1 osimertinib 1 ipatasertib 1 durvalumab 1 dostarlimab 1 cobimetinib 1 atezolizumab 1 alectinib 1 Tyrosine Kinase Inhibitors 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡